Earnings (Loss) Per Share Applicable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to ChromaDex Corporation	$ (1,902)	$ (7,740)
Basic loss per common share (in dollars per share)	$ (0.03)	$ (0.11)
Diluted loss per common share (in dollars per share)	$ (0.03)	$ (0.11)
Basic weighted average common shares outstanding (in shares)	74,796	68,314
Diluted weighted average common shares outstanding (in shares)	74,796	68,314
Potentially dilutive securities:
Restricted stock units (in shares)	945	365
Nonvested shares of restricted stock (in shares)	200	200
Stock options
Potentially dilutive securities:
Stock options (in shares)	12,513	11,954